Bulk drug
名称 | Registration number | Registration status | GMP |
---|---|---|---|
Clopidogrel bisulfate (Type II) | Y20180001218 | A | Pass GMP compliance check |
Clopidogrel bisulfate (Type II, Shandong) | Y20210001051 | A | Pass GMP compliance check |
Pemetrexed disodium 2.5水 | Y20170000046 | A | Pass GMP compliance check |
Pemetrexed disodium 7 water | Y20200001188 | A | Pass GMP compliance check |
Capecitabine (Shandong) | Y20170000125 | A | Pass GMP compliance check |
Nilotinib hydrochloride (Shandong) | Y20210000245 | A | Pass GMP compliance check |
Tenofovir pofol fumarate | Y20200000390 | A | Pass GMP compliance check |
Hydrochlorothiazide (high specification) | Y20190000492 | A | / |
Hydrochlorothiazide | Y20190009621 | A | JS20191091 |
Indapamide |
Y20190009866 Y20180000258 |
A | JS20191091 |
Potassium aspartate | Y20170001251 | A | JS20191091 |
Esomeprazole magnesium | Y20170001661 | A | Pass GMP compliance check |
Esomeprazole sodium | Y20170000446 | A | JS20180961 |
Tigrillo | Y20190000285 | A | Pass GMP compliance check |
Temozolomide | Y20170000549 | A | Pass GMP compliance check |
Bortezomib | Y20170000768 | A | Pass GMP compliance check |
Idebenone | Y20190007001 | A | JS20180847 |
Tenofovir dipifurate fumarate | Y20190006876 | A | JS20180847 |
Erlotinib hydrochloride | Y20180000977 | A | Pass GMP compliance check |
Gefitinib | Y20180001631 | A | Pass GMP compliance check |
Oxaliplatin | Y20190006084 | A | JS20160615 |
Ritodrine hydrochloride | Y20190007663 | A | JS20160615 |
Dacarbazine | Y20190004496 | A | JS20191091 |
Fasudil hydrochloride | Y20190007163 | A | JS20191091 |
Sitagliptin phosphate | Y20210000506 | I | |
Tenofovir dipifurate fumarate (Shandong) | Y20220001270 | I | |
Monoraway | Y20230000004 | I | |
Choline fenofibrate | Y20220001245 | I | |
Esomeprazole Magnesium (Shandong) | Y20230000158 | I | |
Pregabalin (Shandong) | Y20220000631 | I |